157 related articles for article (PubMed ID: 38514210)
1. Advances in familial hypercholesterolemia.
Paquette M; Baass A
Adv Clin Chem; 2024; 119():167-201. PubMed ID: 38514210
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
4. How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
Kataoka Y; Funabashi S; Doi T; Harada-Shiba M
J Atheroscler Thromb; 2022 Jun; 29(6):795-807. PubMed ID: 35022364
[TBL] [Abstract][Full Text] [Related]
5. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
[TBL] [Abstract][Full Text] [Related]
6. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.
Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Mata P
Vasc Health Risk Manag; 2020; 16():11-25. PubMed ID: 32021224
[TBL] [Abstract][Full Text] [Related]
7. Familial Hypercholesterolemia: Global Burden and Approaches.
Tokgozoglu L; Kayikcioglu M
Curr Cardiol Rep; 2021 Sep; 23(10):151. PubMed ID: 34480646
[TBL] [Abstract][Full Text] [Related]
8. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
[TBL] [Abstract][Full Text] [Related]
10. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.
Bell DA; Hooper AJ; Watts GF; Burnett JR
Vasc Health Risk Manag; 2012; 8():651-9. PubMed ID: 23226021
[TBL] [Abstract][Full Text] [Related]
11. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
12. Familial Hypercholesterolemia: Advances in Recognition and Therapy.
Cartier JL; Goldberg AC
Prog Cardiovasc Dis; 2016; 59(2):125-134. PubMed ID: 27477957
[TBL] [Abstract][Full Text] [Related]
13. Detection of familial hypercholesterolemia in patients from a general practice database.
Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
[TBL] [Abstract][Full Text] [Related]
14. DNA testing for familial hypercholesterolemia: improving disease recognition and patient care.
Vergopoulos A; Knoblauch H; Schuster H
Am J Pharmacogenomics; 2002; 2(4):253-62. PubMed ID: 12421096
[TBL] [Abstract][Full Text] [Related]
15. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Robinson JG
J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
[TBL] [Abstract][Full Text] [Related]
16. Past, Present, and Future of Familial Hypercholesterolemia Management.
Rocha VZ; Santos RD
Methodist Debakey Cardiovasc J; 2021; 17(4):28-35. PubMed ID: 34824679
[TBL] [Abstract][Full Text] [Related]
17. Screening and management of familial hypercholesterolemia.
Santos RD
Curr Opin Cardiol; 2019 Sep; 34(5):526-530. PubMed ID: 31393421
[TBL] [Abstract][Full Text] [Related]
18. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
20. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]